BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22193145)

  • 41. Hormone replacement therapy in the menopause: a pro opinion.
    Smith HO; Kammerer-Doak DN; Barbo DM; Sarto GE
    CA Cancer J Clin; 1996; 46(6):343-63. PubMed ID: 8917020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Postmenopausal hormone replacement therapy: does the progestin make a difference?
    Fylstra DL
    J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
    [No Abstract]   [Full Text] [Related]  

  • 43. Practical aspects of hormone replacement therapy.
    Thorneycroft IH
    Prog Cardiovasc Dis; 1995; 38(3):243-54. PubMed ID: 7494885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progestins and recurrence in breast cancer survivors.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2005 Apr; 97(7):471-2. PubMed ID: 15812065
    [No Abstract]   [Full Text] [Related]  

  • 45. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.
    Watts NB; Bilezikian JP; Camacho PM; Greenspan SL; Harris ST; Hodgson SF; Kleerekoper M; Luckey MM; McClung MR; Pollack RP; Petak SM;
    Endocr Pract; 2010; 16 Suppl 3(Suppl 3):1-37. PubMed ID: 21224201
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatments for menopause].
    Lopes P
    Contracept Fertil Sex; 1998 Apr; 26(4):266-78. PubMed ID: 9622961
    [No Abstract]   [Full Text] [Related]  

  • 47. [Do progestins have drawbacks?].
    Sitruk-Ware R
    Contracept Fertil Sex; 1997 May; 25(5):352-7. PubMed ID: 9273105
    [No Abstract]   [Full Text] [Related]  

  • 48. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
    North American Menopause Society
    Menopause; 2011 Jul; 18(7):732-53. PubMed ID: 21685820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Duration of treatment in postmenopausal osteoporosis: how long to treat and what are the consequences of cessation of treatment?
    Laster AJ; Tanner SB
    Rheum Dis Clin North Am; 2011 Aug; 37(3):323-36, v. PubMed ID: 22023894
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.
    Stuenkel CA; Davis SR; Gompel A; Lumsden MA; Murad MH; Pinkerton JV; Santen RJ
    J Clin Endocrinol Metab; 2015 Nov; 100(11):3975-4011. PubMed ID: 26444994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Risks, benefits and costs of hormone replacement therapy in menopause].
    Gaspard U
    Rev Med Liege; 1998 May; 53(5):298-304. PubMed ID: 9689887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Menopause.
    Mishell DR
    Hawaii Med J; 1994 Sep; 53(9):244-5. PubMed ID: 7960713
    [No Abstract]   [Full Text] [Related]  

  • 53. Sex steroids and breast cancer prevention.
    Spicer DV; Pike MC
    J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 Jun; 5(6):513-54. PubMed ID: 10147266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Up-to-date clarification on the menopause hormonal substitutive treatment (HRT) December 2003].
    Afssaps
    Gynecol Obstet Fertil; 2004 Jun; 32(6):571-5; discussion 569-70. PubMed ID: 15217577
    [No Abstract]   [Full Text] [Related]  

  • 56. [The endocrinological and physiological changes in menopause].
    Huhtaniemi I
    Duodecim; 1996; 112(12):1043-51. PubMed ID: 10593004
    [No Abstract]   [Full Text] [Related]  

  • 57. The breast and the menopause.
    Wren BG
    Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):433-47. PubMed ID: 8931904
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of estrogen on screening mammography: another complexity.
    Black WC; Fletcher SW
    J Natl Cancer Inst; 1996 May; 88(10):627-8. PubMed ID: 8627634
    [No Abstract]   [Full Text] [Related]  

  • 59. [Estrogens in menopause – time to change the guidelines?].
    Eriksen EF; Moen MH; Iversen OE
    Tidsskr Nor Laegeforen; 2018 Mar; 138(6):. PubMed ID: 29557135
    [No Abstract]   [Full Text] [Related]  

  • 60. Is there a proven place for phytoestrogens in the menopause?
    Ginsburg J; Prelevic GM
    Climacteric; 1999 Jun; 2(2):75-8. PubMed ID: 11910670
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.